AlphaCentric Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
AlphaCentric Advisors's AZN Position: Q3 2026 in Review
AlphaCentric Advisors increased its AstraZeneca (AZN) stake by 4.1% in Q3 2026, buying an estimated $78.7K and bringing the position to 11,866 shares worth $1.92M. The position accounts for 1.7% of the portfolio, ranked #7.
AlphaCentric Advisors first reported a position in AZN in Q4 2024 and has held it in 5 quarters since. The position peaked at $2.22M in Q1 2026. 1,406 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- AlphaCentric Advisors held 11,866 shares of AstraZeneca worth $1.92M as of Q3 2026.
- AlphaCentric Advisors bought 472 AstraZeneca shares in Q3 2026, an estimated $78.7K.
- AstraZeneca made up 1.7% of AlphaCentric Advisors's portfolio in Q3 2026, its #7 holding.
- AlphaCentric Advisors first reported a position in AstraZeneca in Q4 2024 and has held it in 5 quarters since.
- AlphaCentric Advisors's AstraZeneca position peaked at $2.22M in Q1 2026.
- 1,406 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on AlphaCentric Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.